Establishing the performance and acceptability of dried blood spot sampling to screen for islet‐specific autoantibodies
Diabetic Medicine · 2025-08 · 42 (8)
DOI: 10.1111/dme.70071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetic Medicine, online erschienen am 19.05.2025. Verfasst von Siân E Faustini und 11 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Immunology Services, University of Birmingham, Birmingham, UK. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Autoantibodies, Dried Blood Spot Testing, Islets of Langerhans. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research, Diabetes UK, Breakthrough T1D.
Abstract (Originalsprache)
Background
Islet‐specific autoantibodies predate and predict the onset of type 1 diabetes and can be used to screen for presymptomatic disease. Dried blood spots (DBS) offer a convenient and reliable method for community‐based capillary sampling requiring low blood volumes compared to venous collection. We aimed to verify the use of DBS for detecting autoantibodies by the ElisaRSR (3‐screen) multiplex assay compared to venous sampling and also explore the acceptability of DBS sampling.
Methods
Paired serum and DBS samples were collected from healthy controls (HC) and individuals with type 1 diabetes on insulin. Validation and verification of a 3‐screen Islet cell autoantibody (IA‐2A, GADA and ZnT8A) ELISA assay was undertaken for both matrices and compared. Perceived acceptability of DBS testing was explored via semi‐structured interviews with parents and professional stakeholders.
Results
Temporally paired serum and DBS samples were collected for 101 individuals with type 1 diabetes (aged 7–73 years) and 22 HC (aged 18–60 years). Performance characteristics were similar for serum and DBS; sensitivity for serum was 86% compared to 89% for DBS and a specificity of 97% for serum compared to 100% for DBS. Parents ( n = 38) and stakeholders ( n = 25) thought DBS testing offered a minimally invasive, convenient screening test. Parents emphasised choice of screening location, including home and community settings.
Conclusions
DBS sampling can be used as an alternative to serum for use with the 3‐screen assay for general population type 1 diabetes autoantibody screening. DBS sampling appears acceptable to parents and stakeholders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Immunology Services, University of Birmingham, Birmingham, UK.
- College of Medicine and Health, University of Birmingham, Birmingham, UK.
- Department of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
- Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
- Applied Health Directorate, Warwick Medical School, University of Warwick, Coventry, UK.
- Department of Diabetes, University Hospitals of Birmingham, Birmingham, UK.
ORCID-Profile: Siân E Faustini, Lauren M Quinn, Ian Litchfield, Parth Narendran, Alex G Richter
Förderung
- National Institute for Health and Care Research
- Diabetes UK
- Breakthrough T1D
Zitieren
APA
Faustini, S. E., Quinn, L. M., Hoque, M., Young, S., Bentley, C., Kwok, H. F., Plant, T., Litchfield, I., Boardman, F., Greenfield, S. M., Narendran, P., & Richter, A. G. (2025). Establishing the performance and acceptability of dried blood spot sampling to screen for islet‐specific autoantibodies. Diabetic Medicine, 42(8). https://doi.org/10.1111/dme.70071
Vancouver
Faustini SE, Quinn LM, Hoque M, Young S, Bentley C, Kwok HF, et al. Establishing the performance and acceptability of dried blood spot sampling to screen for islet‐specific autoantibodies. Diabetic Medicine. 2025;42(8). doi:10.1111/dme.70071
BibTeX
@article{Faustini2025,
author = {Faustini, Siân E and Quinn, Lauren M and Hoque, Madeeha and Young, Siobhan and Bentley, Christopher and Kwok, Hin-Fai and Plant, Timothy and Litchfield, Ian and Boardman, Felicity and Greenfield, Sheila M and Narendran, Parth and Richter, Alex G},
title = {Establishing the performance and acceptability of dried blood spot sampling to screen for islet‐specific autoantibodies},
journal = {Diabetic Medicine},
year = {2025},
volume = {42},
number = {8},
doi = {10.1111/dme.70071}
}
EUVIMED